1.
Benefits of Rosuvastatin in Cardiovascular Protection Remain Unclear After HOPE-3 . Rev Diabet Stud. 2016;13(4). Accessed January 19, 2026. https://www.diabeticstudies.org/index.php/RDS/article/view/93